中文版 | English
题名

Potential of PKM2 as a drug target in mouse models with type 1 diabetes mellitus

作者
通讯作者Zhou, Zhiguang; Zheng, Peilin
发表日期
2022-04-01
DOI
发表期刊
EISSN
2050-4527
卷号10期号:4
摘要
["Background: This study aimed to determine the effect of PKM2 knockout in STZ induced type 1 diabetes mellitus (T1D) mouse models and to explore the possible mechanism.","Method: PKM2fl/fl C573L/6 mouse was backcrossed with Ins-lcre C57BL/6 mouse to generate beta-cell-specific PKM2 knockout mouse after tamoxifen administration. The expression level of PKM2 in pancreas tissues was detected by quantitative reverse-transcription polymerase chain reaction and western blot analysis. The blood glucose levels in STZ induced T1D mouse models were measured to validate the establishment of T1D models. The pathological changes of T1D mouse were examined by hematoxylin and eosin. The oxidative stress (OS) and inflammatory response in T1D mouse were determined by measuring the expression levels of malondialdehyde, superoxide dismutase, and 8-OHdG in pancreatic tissues and the serum levels of interleukin-6 and tumor necrosis factor-alpha. The ability to catabolize glucose was assessed through intraperitoneal glucose tolerance test and insulin tolerance test.","Results: beta-cell-specific PKM2 knockout was successfully achieved in PKM2fl/flcre+ mouse. T1D mouse with PKM2 knockdown had decreased blood glucose level and suppressed cell apoptosis. PKM2 knockout in T1D mouse attenuated beta cell injury. OS and inflammatory response in T1D mouse with PKM2 knockout were also suppressed compared with T1D mouse without PKM2 knockout.","Conclusion: PKM2 knockout in T1D mouse can attenuate OS and inflammatory response as well as decrease blood glucose level, suggesting the potential of PKM2 as a drug target for T1D treatment."]
关键词
相关链接[来源记录]
收录类别
语种
英语
学校署名
通讯
资助项目
Natural science Foundation of Guangdong Province[2020A1515010085] ; Shenzhen Municipal Science and Technology Innovation Committee Project[JCYJ20190807150619047]
WOS研究方向
Immunology
WOS类目
Immunology
WOS记录号
WOS:000774047500001
出版者
来源库
Web of Science
引用统计
被引频次[WOS]:1
成果类型期刊论文
条目标识符http://sustech.caswiz.com/handle/2SGJ60CL/328458
专题南方科技大学第一附属医院
作者单位
1.Cent South Univ, Dept Metab & Endocrinol, Xiangya Hosp 2, Changsha, Hunan, Peoples R China
2.Cent South Univ, Natl Clin Res Ctr Metab Dis, Key Lab Diabet Immunol, Minist Educ, Changsha, Hunan, Peoples R China
3.Jinan Univ, Clin Med Coll 2, Shenzhen Peoples Hosp,Southern Univ Sci & Technol, Dept Endocrinol,Affiliated Hosp 1, 1017 North Dongmen Rd, Shenzhen 518020, Guangdong, Peoples R China
通讯作者单位南方科技大学第一附属医院
推荐引用方式
GB/T 7714
Liu, Junbin,Li, Zhixia,Huang, Gan,et al. Potential of PKM2 as a drug target in mouse models with type 1 diabetes mellitus[J]. IMMUNITY INFLAMMATION AND DISEASE,2022,10(4).
APA
Liu, Junbin,Li, Zhixia,Huang, Gan,Zhou, Zhiguang,&Zheng, Peilin.(2022).Potential of PKM2 as a drug target in mouse models with type 1 diabetes mellitus.IMMUNITY INFLAMMATION AND DISEASE,10(4).
MLA
Liu, Junbin,et al."Potential of PKM2 as a drug target in mouse models with type 1 diabetes mellitus".IMMUNITY INFLAMMATION AND DISEASE 10.4(2022).
条目包含的文件
条目无相关文件。
个性服务
原文链接
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
导出为Excel格式
导出为Csv格式
Altmetrics Score
谷歌学术
谷歌学术中相似的文章
[Liu, Junbin]的文章
[Li, Zhixia]的文章
[Huang, Gan]的文章
百度学术
百度学术中相似的文章
[Liu, Junbin]的文章
[Li, Zhixia]的文章
[Huang, Gan]的文章
必应学术
必应学术中相似的文章
[Liu, Junbin]的文章
[Li, Zhixia]的文章
[Huang, Gan]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
[发表评论/异议/意见]
暂无评论

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。